Zobrazeno 1 - 10
of 34
pro vyhledávání: '"M. F. López Fernández"'
Autor:
Yanyan Li, Anne Lienhart, Claude Negrier, Iris Jacobs, Elena Santagostino, Lynda Mae Lepatan, M. F. López‐Fernández, F. Abdul Karim, Christine Voigt, Johnny Mahlangu, Denise Wolko, Ingrid Pabinger
Publikováno v:
Haemophilia. 22
Introduction Recombinant factor IX fusion protein (rIX-FP) has been developed to improve the pharmacokinetic (PK) profile of factor IX (FIX), allowing maintenance of desired FIX activity between injections at extended intervals, ultimately optimizing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::517375cc92008d138f84f1718aacbd31
https://doi.org/10.1111/hae.12972
https://doi.org/10.1111/hae.12972
Autor:
B. Brand, T Dvorak, Tung Wynn, M.-F. López Fernández, Brigitt E. Abbuehl, Laimonas Griskevicius, Miranda Chapman, Borislava G. Pavlova, Ralph A. Gruppo
Publikováno v:
Haemophilia, Malden : Wiley-Blackwell Publishing, Inc, 2016, Vol. 22, p. e251-e258
Introduction BAX 855 is a pegylated full-length recombinant factor VIII (rFVIII) with an extended half-life, built on a licensed rFVIII (ADVATE®). BAX 855 demonstrated efficacy and safety in prophylaxis and the treatment of bleeding episodes in prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7853af61569e6cf83cd7ea9d7985c30
https://doi.org/10.1111/hae.12963
https://doi.org/10.1111/hae.12963
Autor:
Gerry Dolan, Jerzy Windyga, M.-F. López Fernández, Bulent Zulfikar, O. Katsarou, Carmen Altisent
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 22(5)
Introduction The bleeding propensity in von Willebrand disease (VWD) is usually moderate or mild and patients with VWD do not need continuous treatment, but do require extra increased haemostatic cover when undergoing dental or surgical procedures. D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa7d9ff2e91b7d7e5dfa9c8f5645c203
https://pubmed.ncbi.nlm.nih.gov/27292438
https://pubmed.ncbi.nlm.nih.gov/27292438
Autor:
Angelika Batorova, M. N. D. Di Minno, Kaan Kavakli, G. Mariani, Alberto Dolce, Pimlak Charoenkwan, Muriel Giansily-Blaizot, N B Mirbehbahani, M.-F. López Fernández, Jørgen Ingerslev, Mehran Karimi, Mariasanta Napolitano
Publikováno v:
Haemophilia
Haemophilia, Wiley, 2015, 21 (6), pp.e513-e517. ⟨10.1111/hae.12782⟩
Haemophilia, Wiley, 2015, 21 (6), pp.e513-e517. ⟨10.1111/hae.12782⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c62aec50b459a17f73b2904a4718f48f
https://hal.umontpellier.fr/hal-01958851
https://hal.umontpellier.fr/hal-01958851
Autor:
J, Windyga, G, Dolan, C, Altisent, O, Katsarou, M-F, López Fernández, B, Zülfikar, B, Zulfikar
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 22(1)
Introduction Desamino D-arginine vasopressin (DDAVP or desmopressin) is a useful and effective haemostatic treatment for patients with von Willebrand Disease (VWD). However, there are still issues regarding in which subtypes of VWD DDAVP is appropria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b55fc905309c24f3bd038679dc931e4a
https://pubmed.ncbi.nlm.nih.gov/26207933
https://pubmed.ncbi.nlm.nih.gov/26207933
Autor:
Macedonio Hernández, Javier Batlle, P. Vila, M. F. López Fernández, M. J. Couselo, José A. Méndez, E. Lourés, E. Rendal, A. Filgueira, J. Torea
Publikováno v:
Annals of Hematology. 75:111-115
The aim of this study was to analyze the ability of an alloantibody from a patient with severe von Willebrand disease (vWD) to interfere with the vWF domain for FVIII, to inhibit factor VIII (FVIII), and to compare it with a rabbit polyclonal antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d017505fb86a012627f88c3f54857ad9
https://doi.org/10.1007/s002770050323
https://doi.org/10.1007/s002770050323
Autor:
M. F. López Fernández, J. Lasierra, B. Justiça, A. F. Villamor, J. L. Navarro, J. Batlle, A. Pardo, Michael Campos
Publikováno v:
Annals of Hematology. 68:111-115
Type IIA von Willebrand disease (vWD) is a heterogeneous disorder for which two different pathogenetic mechanisms have been proposed: increased proteolytic susceptibility of von Willebrand factor (vWF), and/or interference of its post-translational p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86defcf42826226b8045fd3296e6ca5e
https://doi.org/10.1007/bf01727414
https://doi.org/10.1007/bf01727414
Autor:
A, Gringeri, K, Fischer, A, Karafoulidou, R, Klamroth, M F, López-Fernández, E, Mancuso, J, Windyga
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 17(4)
Some 10-20% of bleeding events in haemophilia patients with high-responding inhibitors cannot be controlled with bypassing agents. However, sequential combined bypassing therapy (SCBT) has been reported to be successful in five children. To extend th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::05e7185b50b653afde5841eb257749ad
https://pubmed.ncbi.nlm.nih.gov/21323801
https://pubmed.ncbi.nlm.nih.gov/21323801
Autor:
J, Batlle, M F, López Fernández
Publikováno v:
Sangre. 44(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::866134ddcf8ce6a3584b4a80a42e5267
https://pubmed.ncbi.nlm.nih.gov/10481597
https://pubmed.ncbi.nlm.nih.gov/10481597
Autor:
M. E. Mingot Castellano, C. A. Bradbury, C. Rosso Fernández, I. Thomas, M. T. Alvarez-Román, M. Canaro, I. S. Caparrós Miranda, M. Cappechi, M. Carpenedo, G. Evans, J. T. González-Lopéz, J. R. González-Porras, I. Jarque Ramos, M. L. Lozano-Almela, M. F. Lopez Fernandez, G. Lowe, H. Lyall, C. Pascual Izquierdo, S. Pavord, R. Rayment, P. Roberts, P. Rosique Cortina, B. Sánchez-González, C. Santoro, K. Talks, D. Valcarcel-Ferreiras, F. Zaja
Publikováno v:
HemaSphere, Vol 6, Pp 2177-2178 (2022)
Externí odkaz:
https://doaj.org/article/bf0788336c4b437da1b3277de0b8c41c